Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort

Yanyan Shi,Ralf Strobl,Christian Apfelbacher,Thomas Bahmer,Ramsia Geisler,Peter Heuschmann,Anna Horn,Hanno Hoven,Thomas Keil,Michael Krawczak,Lilian Krist,Christina Lemhöfer,Wolfgang Lieb,Bettina Lorenz-Depiereux,Rafael Mikolajczyk,Felipe A Montellano,Jens Peter Reese,Stefan Schreiber,Nicole Skoetz,Stefan Störk,Jörg Janne Vehreschild,Martin Witzenrath,Eva Grill,NAPKON Study Group,Maria J G T Vehreschild,Jörg J Vehreschild,Hiwa Dashti,Barbara Laumerich,Oliver Pociuli,Nikolaus Büchner,Sabine Adler,Mathias Lehmann,Selcuk Tasci,Maximilian Jorczyk,Thomas Keller,Michael Schroth,Martin Hower,Lukas Eberwein,Tim Zimmermann,Simon-Dominik Herkenrath,Milena Milovanovic,Ramona Pauli,Jörg Simon,Eckard Hamelmann,Christoph Stellbrink,Johannes-Josef Tebbe,Sven Stieglitz,Christoph Wyen,Jan Bosch,Mirko Steinmüller,Christoph Allerlei,Markus Böbel,Elke Natascha Heinitz,Ariane Roecken,Andrea Münckle-Krimly,Christiane Guderian,Ingmar Silberbaur,Harald Schäfer,Claudia Raichle,Christoph Spinner,Bernd Schmeck,Heidi Altmann,Nicole Toepfner,Wolfgang Schmidt,Björn Jensen,Andreas Kremer,Sabine Blaschke,Jochen Dutzmann,Marylyn Addo,Robert Bals,Sven Bercker,Phil-Robin Tepasse,Frank Hanses,Dirk Müller-Wieland,Anette Friedrichs,Jan Rupp,Siri Göpel,Jens Maschmann,Christine Dhillon,Jacob Nattermann,Ingo Voigt,Wilfred Obst,Martin Franz Sprinzl,Christian Scheer,Andreas Teufel,Ulf Günther,Thomas Zoller,Sein Schmidt,Michael Hummel,Julia Fricke,Maria Rönnefarth,Denise Treue,Ludie Kretzler,Chantip Dang-Heine,Paul Triller,Andreas Jooß,Jenny Schlesinger,Natalja Liseweski,Christina Pley,Carmen Scheibenbogen,Marius Hoeper,Philipp A Reuken,Michael von Bergwelt,Rainer Noth,Daniel Drömann,Siegbert Rieg,Istvan Vadasz,Philipp A Koehler,Uta Merle,Astrid Petersmann,Claudia Ellert,Georg Schmidt,Janne Vehreschild,Katrin Milger,Marie von Lilienfeld,Oliver Witzke,Patrick Meybohm,Sandra Frank,Thomas Illig Alexander Hein,Andrea Wittig,Andreas Simm,Anke Reinacher-Schick,Anna Frey,Antonella Iannaccone,Benjamin Maasoumy,Benjamin Waschki,Bimba Hoyer,Brigitt van Oorschot,Carolina van Schaik,Christina Polidori,Christine Klein,Daniel Medenwald,Eva Christina Schulte,Felix Meinel,Folke Brinkmann,Ghazal Arabi,Heike Bickeböller,Holger Lindner,Ildiko Gagyor,Jessica Hassel,Jürgen Deckert,Katrin Milger-Kneidinger,Kerstin Ludwig,Marcus Dörr,Marie von Lilienfeld-Toal,Martin Möckel,Martin Weigl,Matthias Nauck,Miriam Banas,Muenevver Demir,Nicole Lindenberg,Nora Hettich,Norma Jung,Orlando Guntinas-Lichius,Reinhard Berner,Samuel Knauss,Sebastian Baumeister,Sebastian Dolff,Selma Ugurel,Sophia Stöcklein,Stefanie Joos,Winfred Häuser Jörg Janne Vehreschild,Maximilian Schons,Sina Hopff,Markus Brechtel,Cristina Schmidt-Ibanez,Johannes Schneider,Carolin Jakob,Franziska Voß Inga Bernemann,Sonja Kunze,Maike Tauchert,Thomas Illig,Gabriele Anton Cornelia Fiessler,Mirjam Kohls,Olga Miljukov,Steffi Jiru-Hillmann,Jens-Peter Reese,Peter Heuschmann Jens-Peter Reese,Anna-Lena Hofmann,Julia Schmidt,Kathrin Ungethüm,Michael Krawczak Thomas Bahmer,Daniel Pape,Anne Hermes,Irene Lehmann,Corina Maetzler,Lukas Tittmann Roberto Lorbeer,Monika Kraus,Christian Schäfer,Jens Schaller,Mario Schattschneider,Dana Stahl,Heike Valentin,Dagmar Krefting,Matthias Nauck Nicole Toepfner,Reinhard Berner Christof von Kalle,Sylvia Thun,Alexander Bartschke,Liudmila Lysyakova,Stefanie Rudolph,Julian Sass Eike Nagel,Valentina Püntmann,Tammy Wolf,Thourier Azdad,Franziska Weis,Ira Krückemeier,Simon Bohlender,Deniz Desik,Layla Laghchioua,Ralf Heyder,Silke Wiedmann
DOI: https://doi.org/10.1007/s15010-023-02043-6
Infection
Abstract:Purpose: We aimed to assess symptoms in patients after SARS-CoV-2 infection and to identify factors predicting prolonged time to symptom-free. Methods: COVIDOM/NAPKON-POP is a population-based prospective cohort of adults whose first on-site visits were scheduled ≥ 6 months after a positive SARS-CoV-2 PCR test. Retrospective data including self-reported symptoms and time to symptom-free were collected during the survey before a site visit. In the survival analyses, being symptom-free served as the event and time to be symptom-free as the time variable. Data were visualized with Kaplan-Meier curves, differences were tested with log-rank tests. A stratified Cox proportional hazard model was used to estimate adjusted hazard ratios (aHRs) of predictors, with aHR < 1 indicating a longer time to symptom-free. Results: Of 1175 symptomatic participants included in the present analysis, 636 (54.1%) reported persistent symptoms after 280 days (SD 68) post infection. 25% of participants were free from symptoms after 18 days [quartiles: 14, 21]. Factors associated with prolonged time to symptom-free were age 49-59 years compared to < 49 years (aHR 0.70, 95% CI 0.56-0.87), female sex (aHR 0.78, 95% CI 0.65-0.93), lower educational level (aHR 0.77, 95% CI 0.64-0.93), living with a partner (aHR 0.81, 95% CI 0.66-0.99), low resilience (aHR 0.65, 95% CI 0.47-0.90), steroid treatment (aHR 0.22, 95% CI 0.05-0.90) and no medication (aHR 0.74, 95% CI 0.62-0.89) during acute infection. Conclusion: In the studied population, COVID-19 symptoms had resolved in one-quarter of participants within 18 days, and in 34.5% within 28 days. Over half of the participants reported COVID-19-related symptoms 9 months after infection. Symptom persistence was predominantly determined by participant's characteristics that are difficult to modify.
What problem does this paper attempt to address?